ArticleAsian Pacific journal of cancer prevention : APJCP2026
Assessment of Pathtezt® Infinity Processor and Autoloader Efficiency in Cervical Smear Analysis.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess the cellularity, epithelial cell coverage, cellular arrangement, preservation, and interfering factors of cervical cytological smears produced by the PathTezt® Infinity with Autoloader. METHODOLOGY: A total of 1003 Pap smear samples were taken from Hospital Pakar Universiti Sains Malaysia and Hospital Raja Perempuan Zainab II and processed using the PathTezt® Infinity. The slides were evaluated for smear adequacy, epithelial cells coverage, cellular arrangement, interfering factors, and cellular preservation.
resultsApproximately 946 samples (94.1%) were adequate for evaluation. The evaluation of cellular arrangement demonstrated good dispersion in 860 samples (85.7%), while 94.7% of the samples exhibited minimal to no obscuration by inflammatory cells. The presence of erythrocytes did not impede the evaluation of squamous cells in 1002 smears (99.9%). All smears showed good-quality fixation features for nuclear, cytoplasmic, and microorganism evaluation. The overall "good" performance rate was 97.7%. Chi-square analysis between the scoring categories and criteria for scoring showed statistical significance (p < 0.001).
conclusionThe PathTezt® Infinity with Autoloader produces high-quality smears, is easy to operate, fully walk-away, and cost-effective, making it suitable for cervical cancer screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.